Earnings call Pacira BioSciences delivered solid Q1 2026 results, with EXPAREL net sales up 5% YoY to $143.3M, ZILRETTA up 15% to $26.8M, and iovera up 21% to $6.2M. Management reiterated full-year ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results